PE20070125A1 - NON-STEROID PROGESTERONE RECEPTOR MODULATORS - Google Patents
NON-STEROID PROGESTERONE RECEPTOR MODULATORSInfo
- Publication number
- PE20070125A1 PE20070125A1 PE2006000733A PE2006000733A PE20070125A1 PE 20070125 A1 PE20070125 A1 PE 20070125A1 PE 2006000733 A PE2006000733 A PE 2006000733A PE 2006000733 A PE2006000733 A PE 2006000733A PE 20070125 A1 PE20070125 A1 PE 20070125A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- methyl
- progesterone receptor
- receptor modulators
- benzoxazin
- Prior art date
Links
- 239000002379 progesterone receptor modulator Substances 0.000 title 1
- 229940095745 sex hormone and modulator of the genital system progesterone receptor modulator Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical group [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000003998 progesterone receptors Human genes 0.000 abstract 1
- 108090000468 progesterone receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE R1 Y R2 SON CADA UNO H, ALQUILO C1-C5 LINEAL O NO LINEAL, RAMIFICADO O NO; R3 ES CC-Ra; Ra ES H, ALQUILO C1-C8, ALQUENILO C2-C8, CICLOALQUILO C3-C10, ENTRE OTROS; R4 ES H, METILO, ETILO, ALQUILO C1-C3 PARCIAL O TOTALMENTE FLUORADO; A ES ANILLO AROMATICO MONO O BICICLICO, CARBOCICLICO O HETEROCICLICO, OPCIONALMENTE MONO O POLI SUSTITUIDO CON ALQUILO C1-C8, ALQUENILO C2-C8, PERFLUOROALQUILO C1-C6, ENTRE OTROS; B ES CARBONILO, CH2. SON COMPUESTOS PREFERIDOS: (-)-6-{2-[2-(2,3-(METILENDIOXI)FENIL)-2-METILPROPIL]-2-HIDROXI-OCT-3-INAOIL}-4-METIL-2,3-BENZOXAZIN-1-ONA; 6-{2-[2-(2,3-DIHIDRO-7-BENZOFURANIL)-2-METILPROPIL]-2-HIDROXI-3-OCTINILAMINO}-4-METIL-2,3-BENZOXAZIN-1-ONA; ENTRE OTROS. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON MODULADORES NO ESTEROIDES DE RECEPTOR DE PROGESTERONAIT REFERS TO A COMPOUND OF FORMULA I, WHERE R1 AND R2 ARE EACH H, C1-C5 ALKYL LINEAR OR NON-LINEAR, BRANCHED OR NOT; R3 IS CC-Ra; Ra IS H, C1-C8 ALKYL, C2-C8 ALKENYL, C3-C10 CYCLOALKYL, AMONG OTHERS; R4 IS H, METHYL, ETHYL, C1-C3 ALKYL PARTIALLY OR FULLY FLUORATED; A IS AROMATIC RING, MONO OR BICYCLIC, CARBOCYCLIC OR HETEROCICLIC, OPTIONALLY MONO OR POLY, SUBSTITUTED WITH C1-C8 ALKYL, C2-C8 ALKENYL, C1-C6 PERFLUOROALKYL, AMONG OTHERS; B IS CARBONYL, CH2. PREFERRED COMPOUNDS ARE: (-) - 6- {2- [2- (2,3- (METHYLEDIOXY) PHENYL) -2-METHYLPROPYL] -2-HYDROXY-OCT-3-INAOYL} -4-METHYL-2,3 -BENZOXAZIN-1-ONA; 6- {2- [2- (2,3-DIHYDRO-7-BENZOFURANIL) -2-METHYLPROPYL] -2-HYDROXY-3-OCTINYLAMINO} -4-METHYL-2,3-BENZOXAZIN-1-ONA; AMONG OTHERS. ALSO REFERRED TO A PHARMACEUTICAL COMPOSITION. SUCH COMPOUNDS ARE NON-STEROID MODULATORS OF PROGESTERONE RECEPTOR
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005030292A DE102005030292A1 (en) | 2005-06-24 | 2005-06-24 | Nonsteroidal progesterone receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20070125A1 true PE20070125A1 (en) | 2007-02-14 |
Family
ID=37199176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000733A PE20070125A1 (en) | 2005-06-24 | 2006-06-26 | NON-STEROID PROGESTERONE RECEPTOR MODULATORS |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1902049A2 (en) |
| JP (1) | JP2008543910A (en) |
| KR (1) | KR20080030622A (en) |
| CN (1) | CN101248066A (en) |
| AR (1) | AR054519A1 (en) |
| AU (1) | AU2006261048A1 (en) |
| BR (1) | BRPI0611903A2 (en) |
| CA (1) | CA2611897A1 (en) |
| CR (1) | CR9598A (en) |
| DE (1) | DE102005030292A1 (en) |
| DO (1) | DOP2006000148A (en) |
| EA (1) | EA200702524A1 (en) |
| EC (1) | ECSP078044A (en) |
| GT (1) | GT200600271A (en) |
| IL (1) | IL188021A0 (en) |
| MX (1) | MX2008000072A (en) |
| NO (1) | NO20080440L (en) |
| PE (1) | PE20070125A1 (en) |
| TW (1) | TW200740778A (en) |
| UY (1) | UY29624A1 (en) |
| WO (1) | WO2006136461A2 (en) |
| ZA (1) | ZA200800690B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY30805A1 (en) * | 2006-12-21 | 2008-07-31 | Bayer Schering Pharma Ag | NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS |
| DE102007032800A1 (en) * | 2007-07-10 | 2009-01-15 | Bayer Schering Pharma Aktiengesellschaft | Nonsteroidal progesterone receptor modulators |
| DE102007058747A1 (en) * | 2007-12-05 | 2009-06-10 | Bayer Schering Pharma Aktiengesellschaft | Nonsteroidal progesterone receptor modulators |
| JP2011519916A (en) * | 2008-07-02 | 2011-07-14 | ファーマコステック カンパニー リミテッド | Method for producing amide derivative |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19856475A1 (en) * | 1998-11-27 | 2000-05-31 | Schering Ag | Nonsteroidal anti-inflammatories |
| EP1344776A1 (en) * | 2002-03-11 | 2003-09-17 | Schering Aktiengesellschaft | 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders |
| RS20050974A (en) * | 2003-07-01 | 2007-09-21 | Schering Aktiengesellschaft, | Heterocyclically substituted pentanol derivatives,method for the production thereof,and use thereof as anti- inflammatory agents |
-
2005
- 2005-06-24 DE DE102005030292A patent/DE102005030292A1/en not_active Ceased
-
2006
- 2006-06-22 EA EA200702524A patent/EA200702524A1/en unknown
- 2006-06-22 KR KR1020087001793A patent/KR20080030622A/en not_active Withdrawn
- 2006-06-22 EP EP06762404A patent/EP1902049A2/en not_active Withdrawn
- 2006-06-22 BR BRPI0611903-4A patent/BRPI0611903A2/en not_active Application Discontinuation
- 2006-06-22 CN CNA2006800308707A patent/CN101248066A/en active Pending
- 2006-06-22 WO PCT/EP2006/006531 patent/WO2006136461A2/en not_active Ceased
- 2006-06-22 AU AU2006261048A patent/AU2006261048A1/en not_active Abandoned
- 2006-06-22 MX MX2008000072A patent/MX2008000072A/en not_active Application Discontinuation
- 2006-06-22 CA CA002611897A patent/CA2611897A1/en not_active Abandoned
- 2006-06-22 JP JP2008517444A patent/JP2008543910A/en active Pending
- 2006-06-23 TW TW095122742A patent/TW200740778A/en unknown
- 2006-06-26 UY UY29624A patent/UY29624A1/en not_active Application Discontinuation
- 2006-06-26 DO DO2006000148A patent/DOP2006000148A/en unknown
- 2006-06-26 PE PE2006000733A patent/PE20070125A1/en not_active Application Discontinuation
- 2006-06-27 AR ARP060102750A patent/AR054519A1/en unknown
- 2006-06-28 GT GT200600271A patent/GT200600271A/en unknown
-
2007
- 2007-12-10 IL IL188021A patent/IL188021A0/en unknown
- 2007-12-17 CR CR9598A patent/CR9598A/en not_active Application Discontinuation
- 2007-12-21 EC EC2007008044A patent/ECSP078044A/en unknown
-
2008
- 2008-01-23 ZA ZA200800690A patent/ZA200800690B/en unknown
- 2008-01-23 NO NO20080440A patent/NO20080440L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200702524A1 (en) | 2008-06-30 |
| IL188021A0 (en) | 2008-03-20 |
| DOP2006000148A (en) | 2007-07-15 |
| CR9598A (en) | 2008-04-09 |
| EP1902049A2 (en) | 2008-03-26 |
| UY29624A1 (en) | 2007-01-31 |
| MX2008000072A (en) | 2008-03-24 |
| KR20080030622A (en) | 2008-04-04 |
| TW200740778A (en) | 2007-11-01 |
| ECSP078044A (en) | 2008-01-23 |
| ZA200800690B (en) | 2009-09-30 |
| DE102005030292A1 (en) | 2007-01-11 |
| GT200600271A (en) | 2007-02-05 |
| BRPI0611903A2 (en) | 2010-10-05 |
| JP2008543910A (en) | 2008-12-04 |
| NO20080440L (en) | 2008-03-25 |
| CN101248066A (en) | 2008-08-20 |
| AR054519A1 (en) | 2007-06-27 |
| CA2611897A1 (en) | 2006-12-28 |
| AU2006261048A1 (en) | 2006-12-28 |
| WO2006136461A2 (en) | 2006-12-28 |
| WO2006136461A3 (en) | 2007-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR058005A1 (en) | FLUORATED DERIVATIVES OF 4- (2- AMINO-1-HYDROXYETHYL) PHENOL AS BETA 2 ADRENERGIC RECEPTOR AGONISTS | |
| PE20071022A1 (en) | COMPOUNDS DERIVED FROM DIBENCILAMINE AS INHIBITORS OF CHOLESTERYL ESTER TRANSFER PROTEIN (CEPT) | |
| PE20081679A1 (en) | PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE | |
| DE602005016775D1 (en) | HETEROCYCLIC AZOL-CONTAINING SULFONAMIDINHIBITORS OF BETA AMYLOID PRODUCTION | |
| PE20141375A1 (en) | GLUCOKINASE ACTIVATORS | |
| AR054814A1 (en) | PIRIDAZINE DERIVATIVES | |
| PE20081530A1 (en) | NEW COMPOUNDS 617 | |
| AR050691A1 (en) | ISOINDOLONE COMPOUNDS AS POTENTIALS OF THE METABOTROPIC GLUTAMATE RECEIVER. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS. | |
| PE20090218A1 (en) | GLUCOCORTICOID MIMETIC COMPOUNDS, METHODS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS | |
| DK1912979T3 (en) | Phenyl {3- {3- (1H-pyrrol-2-YL) - [1,2,4] oxadiazol-5-YL] piperidin-1-YL} methanone derivatives and related compounds as positive allosteric modulators of metabotrope glutamate receptors | |
| PE20091952A1 (en) | TIAZOLE AND OXAZOLE COMPOUNDS OF BENZENE SULFONAMIDE | |
| PE20120790A1 (en) | 2-MERCAPTOQUINOLIN-3-CARBOXAMIDES SUBSTITUTED AS KCNQ2 / 3 MODULATORS | |
| AR055150A1 (en) | ISOINDOL COMPOUNDS - IMIDO AND COMPOSITIONS THAT INCLUDE THEM AND THEIR METHODS OF USE | |
| PE20081532A1 (en) | NOVEL COMPOUNDS | |
| PE20080677A1 (en) | PYRROLOTRIAZINE INHIBITORS CINAZA | |
| AR071385A1 (en) | COMPOUNDS OF 2-IMINO-3-METHYL PIRROLOPIRIMIDINONE REPLACED WITH THIOPHENYLL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND USE OF THE SAME FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH THE BETA AMYLOID PROTEIN, SUCH AS ALZHEIMAS DE OMOSTER DE OMOS. | |
| PE20140868A1 (en) | TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS | |
| AR075084A1 (en) | PREPARATION METHOD OF QUINOLINIL -OXIDIFENIL - CYCLOPROPANODICARBOXAMIDS AND CORRESPONDING INTERMEDIARIES | |
| CO6231008A2 (en) | FENOXI THIAZOLIDINDIONAS REPLACED AS MODULATORS OF THE ALFA RECEIVER RELATED TO THE STROGEN | |
| PE20120113A1 (en) | NEW DERIVATIVES OF BENZOTIADIAZEPINES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| PE20110875A1 (en) | DERIVATIVES OF ISOINDOL AS BACE INHIBITORS | |
| PE20091102A1 (en) | IMIDAZOLO-, OXAZOLO-, AND THIAZOLOPYRIMIDINE MODULATORS OF TRPV1 | |
| PE20070495A1 (en) | QUATERNARY COMPOUNDS DERIVED FROM alpha-AMINOCARBOXIAMIDE AS MODULATORS OF SODIUM CHANNELS WITH OPENING BY VOLTAGE | |
| PE20090655A1 (en) | DERIVATIVES OF 2-AZA-BICYCLE [2.2.2] OCTANE FOR THE PREVENTION OR TREATMENT OF PSYCHOSIS | |
| PE20091524A1 (en) | DERIVATIVES OF 2-AMINOPYRIMIDINE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |